Author:
Tsunehiro Masaya,Sasaki Kenji,Kinoshita-Kikuta Emiko,Kinoshita Eiji,Koike Tohru
Subject
Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry
Reference29 articles.
1. The chemical evolution of oligonucleotide therapies of clinical utility;Khvorova;Nat. Biotech.,2017
2. Oligonucleotide therapeutics as a new class of drugs for malignant brain tumors: Targeting mRNAs, regulatory RNAs, mutations, combinations, and beyond;Krichevsky;Neurotherapeutics,2019
3. C.A. Stein, D. Castanotto, FDA-approved oligonucleotide therapies in 2017, Mol. Ther. 25 (2017) 1069–1075. https://dx.doi.org/10.1016/j.ymthe.2017.03.023.
4. Nucleic-acid therapeutics: Basic principles and recent applications;Opalinska;Nat. Rev. Drug Discov.,2002
5. Impurities in oligonucleotide drug substances and drug products;Capaldi;Nucleic Acid Ther.,2017
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献